By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SAIC-Frederick today said that it is collaborating with Biomatrica on developing better processes for isolating nucleic acids from tumor samples collected by pathologists in clinics.
Registering provides access to this and other free content.
Already have an account?Login Now.
This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.
Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.
Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.
A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.